TD Cowen analyst Phil Nadeau maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $225 to $250.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
Penguin Solutions, Broadcom, FormFactor, Lattice Semiconductor, and AMD stocks trade up, what you need to know
Yahoo2 Hours Ago
S&P Global: 3 Key Takeaways for Long-Term Investors
Yahoo2 Hours Ago
S&P Global vs. Toast: Which Financial Stock Is a Better Buy in 2026?
Yahoo2 Hours Ago
Noble Q3 Earnings Call Highlights
Yahoo2 Hours Ago
Update: CoStar Group Q3 Adjusted Earnings, Revenue Rise; Issues Q4 Guidance; Lifts 2026 Guidance
Yahoo3 Hours Ago
Alpaca · SIPUpdated 16:00 NY15 Minutes Delayed
